Amit Mahipal, MD, and Danny Nguyen, MD

All articles by Amit Mahipal, MD, and Danny Nguyen, MD

Risks and Benefits of Phase 1 Clinical Trial Participation

October 30, 2014

[Cancer Control] There are long-lasting positive and negative impacts on those patients who choose to participate in phase 1 clinical trials, but participant safety is a priority.

Next post in General Oncology

Amit Mahipal, MD, and Danny Nguyen, MD

All articles by Amit Mahipal, MD, and Danny Nguyen, MD

Risks and Benefits of Phase 1 Clinical Trial Participation

Burnout Found in Most Palliative Care Clinicians